endogene.bio was awarded funding through Innov'up, a program supported by Bpifrance that provides financial and strategic support to high-potential innovative companies. Designed to accelerate the development of breakthrough technologies, Innov'up helps startups transform ambitious research projects into real-world impact.
The award will support the next stage of endogene.bio's development efforts in women's health. This milestone reflects continued recognition of the company's work to generate the biological data needed to improve disease understanding, diagnosis, and therapeutic development in uterine health.
About endogene.bio
endogene.bio generates high-resolution biological data from menstrual blood, unlocking a previously inaccessible layer of human uterine biology. Our platform enables disease understanding, patient stratification, and therapeutic discovery across uterine health.
